Abstract: Stigma reduction programs are dominated by a biomedical model that presents depression as a medical illness. Alternately, a contextual model emphasizes that one should not be blamed for environmental influences. This study compared biomedical, contextual, and control stigma reduction programs to each other and to a no-program control. The main hypotheses were that the contextual program would have the greatest impact and that a match between participants' beliefs about depression and the model presented would moderate this effect. Seventy-four participants were randomized to the 3 programs and 12 participants served as a no-program control. The contextual and control programs reduced stigma significantly compared with the no-program control, whereas the biomedical program did not. Beliefs about depression moderated this effect only for the biomedical condition. Contextual and control programs seem to be effective but a biomedical model may be risky for those who disagree with the model. Theoretical implications are discussed.
A ccording to the World Health Organization, major depression is the "most burdensome disease in the world" among middle aged adults (Murray and Lopez, 1996) . Despite the availability of efficacious treatments for depression (DeRubeis and Crits-Christoph, 1998) , most depressed individuals do not seek treatment (Regier et al., 1993) , and 1 widely recognized factor for this is stigma: negative attitudes about mental illness and treatment shared by both the general public and individuals with the stigmatized condition (Corrigan, 2005) . In response to this concern, many organizations have designed and disseminated stigma reduction programs. Typically, these programs are partially funded by the pharmaceutical industry and informed by mainstream media conceptualizations of depression, resulting in efforts that are overwhelmingly biomedical in content (e.g., NAMI's "Mental Illness is a Brain Disease"). These programs present depression as a medical illness, like diabetes, and it is argued that individuals with such illnesses should not be stigmatized.
There are several reasons why these programs may not be as effective as initially hoped. First, they underemphasize well-established contextual factors in depression, such as unemployment, poverty, loss of a loved one, and trauma (Kessler, 1997) . Second, the programs are not sensitive to how the majority of depressed individuals view depression (Brown et al., 2000) or to their treatment preferences (Dwight-Johnson et al., 2000) . Third, the biomedical model has been found to preclude consideration of other possible explanations for mental illness (Schreiber and Hartrick, 2002) , increase helplessness (Farina et al., 1978) , and decrease self-efficacy and help-seeking (Fisher and Farina, 1979) .
Alternately, recent interest has been generated in a contextual model of depression due to increasing empirical support for behavioral activation (Cuijpers et al., 2007; Dimidjian et al., 2006) , a treatment based on this model. The contextual model presents depression as a consequence of the contextual factors described above (Hayes et al., 1999; Jacobson, 1997; Kanter et al., 2006; Leventhal and Martell, 2006; Martell et al., 2001) and is more consistent with how most individuals view depression (Brown et al., 2001 ). In addition, variations on the contextual model have been found to decrease fear toward individuals with mental illness (Morrison, 1980; Morrison et al., 1979) , decrease ratings of dangerousness and unpredictability of individuals with mental illness (Read and Law, 1999; Walker and Read, 2002) , and increase positive images of individuals with mental illness (Morrison, 1980) . This previous research generally was laboratory based and not conducted within the context of stigma reduction programs. The purpose of this study, therefore, was to compare biomedical versus contextual models of depression in the context of stigma reduction programs.
The effectiveness of stigma reduction programs about depression also may be influenced by individuals' preexisting beliefs about depression. In the treatment outcome literature, a match between preexisting beliefs about depression and the treatment model presented has been found to positively impact treatment outcome (Addis and Jacobson, 1996; Addis and Carpenter, 1999; Fennell and Teasdale, 1987) . Translating this research to antistigma settings, it is possible that beliefs about depression will exert a similar influence in that a match between preexisting beliefs and the model presented will produce greater stigma reduction. In other words, individuals whose beliefs about depression tend toward the biological may be more positively influenced by a program emphasizing a biomedical model, whereas those with preexisting contextual beliefs may be more influenced by a contextual program.
Biomedical and contextual stigma reduction programs also may result in differential self-reported behavioral intentions and treatment seeking. Specifically, the biomedical model, compared with a contextual model, has been found to decrease intentions to seek help, decrease efforts to deal with problems, decreased perceived curability, increase helplessness about solving mental health problems, and increase pessimism about recovery from mental disorders (Farina et al., 1978; Fisher and Farina, 1979; Lam et al., 2005; Lam and Salkovskis, 2007) . Furthermore, the biomedical model has been found to lead to recommendations for inpatient hospitalization or medication rather than psychotherapy (Phelan et al., 2006) . In contrast, the contextual model, as used in treatment settings, focuses directly on contextual variables that are amenable to change and is used to activate individuals to work toward those changes (Martell et al., 2001) . Thus, applied to stigma reduction the contextual model may engender greater self-reported behavioral intentions and greater treatment seeking.
The purpose of the current study was to examine the effects of a contextual model and a biomedical model of stigma reduction for depression, comparing these programs to each other and to a control program, as well as a no-program control condition. Primary hypotheses focused on changes in stigmatizing attitudes immediately after the stigma reduction programs, but stability at 1-week and 1-month follow-ups was also assessed. First, it was predicted that a contextual program would be more effective in reducing stigmatizing attitudes than a biomedical program, control program, and no-program control. Second, it was predicted that both programs would be more effective in reducing stigmatizing attitudes when they matched participants' preexisting beliefs about depression. Third, it was predicted that a contextual program would engender greater behavioral intentions and treatment seeking than would the biomedical or control program.
METHODS

Participants
Participants were 86 undergraduate psychology students who received course extra credit for participation. The sample was 72.1% female with a mean age of 21.45 (SD ϭ 6.30). Regarding ethnicity, 86% was white, 8% Asian American, 4% African American, 1% Mexican American, and 1% "other."
Procedures
Seventy-four of the 86 participants were randomly assigned to 1 of 3 active intervention conditions: a contextual stigma reduction program, a biomedical stigma reduction program, or a control stigma reduction program. These participants were run in groups. Participants first provided informed consent, completed a set of questionnaires assessing demographic variables and preexisting beliefs about depression (T0), viewed a stigma reduction program, and then completed a set of questionnaires about stigma (T1). Participants returned 1-week (T2) and 1-month later (T3) to complete follow-up assessments. The sample size at T2 was 64 and at T3 was 53.
All 3 programs involved a Powerpoint slide presentation with voice-over narration for each slide. All programs started with a discussion of depression stigma, and the contextual and biomedical programs additionally included information specific to each model about the causes and treatment of depression. These sections were similar in format (similar sentence structures and emphases of importance). All 3 programs ended with a discussion of how to support individuals with depression. The programs were based on a stigma reduction program developed by a community agency (InHealth Wisconsin, 2006) . The contextual and biomedical programs were 10 minutes long and the control program was 6 minutes long. All programs are available from the first author.
Contextual Program
The contextual program was based on behavioral activation (Martell et al., 2001) and discussed how depression is triggered by negative events such as losses, transitions, and relationship difficulties. The model explained the cause of depression as, "depression is a result of complicated life stressors that contribute to sleeplessness, reduced activity, anxiety, and the low mood of depression." This was followed by images of negative life events. Following this, psychotherapeutic treatment approaches were discussed.
Biomedical Program
The biomedical program discussed how depression is caused by chemical imbalances, particularly focusing on the neurotransmitters serotonin, dopamine, and norepinphrine. The model explained the cause of depression as, "depression is a result of chemical imbalances that contribute to sleeplessness, reduced activity, anxiety, and the low mood of depression." This was followed by images of neurotransmitters and neural transmission. Following this, pharmacologic approaches to treating depression were discussed.
Control Program
The control program addressed depression stigma but did not discuss the biomedical or contextual model of depression. For example, the program stated, "Individuals who experience depression are often directly affected by stigma. Stigma often causes individuals to keep their depression to themselves because they fear the repercussions of lettings others know."
No-Program Control
Because of the length of the programs, we felt it imprudent to administer the same measures before and after the programs, as this would increase demand characteristics and might result in distorted postprogram scores. As an alternative to preprogram measurement, additional participants were recruited to serve as a no-program control condition and were administered the measures the active conditions completed at T0 and T1. They were not randomly assigned and only completed measures at T0. These participants were not randomly assigned because we had begun recruiting for the active conditions when the no-program control was added to the study.
Measures
The Center for Epidemiologic Studies Depression Scale
The Center for Epidemiologic Studies Depression Scale (Radloff, 1977 ) is a well-used 20-item self-report questionnaire that assesses type and severity of current depressive symptoms with higher scores indicating higher levels of depression. The Center for Epidemiologic Studies Depression Scale was administered at T0.
Beliefs About Depression
Beliefs about depression were assessed with two 3-item subscales from Goldstein and Rosselli (2003) . Participants rate each item on a 7-point scale with higher scores indicating stronger beliefs. Items include, "A chemical or hormonal imbalance in the brain or nervous system" and "Response to a negative life event (health, status, and work)." The environmental beliefs (␣ ϭ 0.66) and the biological beliefs (␣ϭ 0.69) subscale both had moderate internal consistency in the current study. These subscales were administered at T0.
Depression Attribution Questionnaire-27
The Attribution Questionnaire-27 (Corrigan et al., 2003) , a well-used 27-item scale designed to measure stigmatizing attitudes about schizophrenia, was modified to assess attitudes about depression, resulting in the DAQ-27. Participants rate each item on a 9-point scale with higher scores indicating higher levels of stigma. Participants are asked specific questions about the following vignette, "Harry is a 30-year-old single man with severe depression. He feels hopeless about life and becomes upset. He lives alone in an apartment and works as a clerk at a large law firm. He has been hospitalized 6 times because of suicidality." Items include, "How much concern would you feel for Harry?," "If I were a landlord, I probably would rent an apartment to Harry" and "How dangerous would you feel Harry is?" The DAQ-27 demonstrated high internal consistency in a depressed sample (n ϭ 391, ␣ ϭ 0.82; Kanter et al., 2008) . The DAQ-27
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Behavioral Intentions
Three subscales from Goldstein and Rosselli's (2003) measure were administered to assess behavioral intentions: self-reported activation and engagement in the environment to cope with depression. Participants rate each item on a 7-point scale with higher scores indicating greater behavioral intentions. The subscales assessed behavioral intentions toward significant others, close friends, and parents. Each subscale assessed how willing the individual was to tell that person about depression, whether they would ask for help, and the effectiveness of help received. The subscales demonstrated moderate internal consistency in the current study (␣s ranged from 0.65-0.75). These subscales were administered at T1, T2, and T3 for the active conditions.
Treatment-Seeking Questionnaire
Treatment seeking since the start of the study was assessed with the 2 following self-report questions at T2 and T3: "Since this study began 1 week ago (4 weeks ago), have you: considered seeking help for depression or related problems, made any attempt to seek help (e.g., phone calls, asking family or friends about services), or sought help for depression?" and "If you have sought help for depression in the past week (4 weeks), what did you seek: medication, therapy, other?"
RESULTS
Preliminary Analyses
There were no significant differences among participants in the 4 conditions in age, gender, depression severity, or endorsement of biological or environmental beliefs about depression (Table 1) . There were also no significant differences on these variables between those who returned for the follow-up assessments versus those who did not.
Stigma Reduction
Because the DAQ-27 was only administered to participants in the no-program control condition once, first an ANOVA between the 3 active conditions at T1 and the no-program control at T0 was conducted. This indicated a significant difference between conditions, F (3, 77) ϭ 3.348, p ϭ 0.023. Posthoc Bonferroni corrected t tests indicated that individuals in the contextual (p ϭ 0.035, d ϭ 1.21) and control (p ϭ 0.023, d ϭ 1.13) conditions exhibited significantly less stigma than individuals in the no-program control, whereas individuals in the biomedical condition did not statistically differ in level of stigma from those in the no-program control (Table  2) . However, the effect size for this last comparison was large (d ϭ 0.82), suggesting power may have been an issue in this analysis.
To explore differences between active conditions across the follow-up points, a repeated measures ANOVA with DAQ-27 scores as the dependent variable and condition and time as independent variables was conducted. The main effects for condition, F (2, 70) ϭ 1.23, p ϭ 0.298, and time, F (2, 70) ϭ 0.82, p ϭ 0.446, were not significant, nor was the interaction between condition and time, F (4, 70) ϭ 0.44, p ϭ 0.780, indicating no differences between active conditions in stigma at follow-up points.
Beliefs About Depression
To determine whether a match between participants' beliefs about depression and the model of depression presented in the stigma programs influenced stigma reduction, a dummy code was created to indicate whether a participant was in a matched or mismatched condition. For example, an individual was classified as a match if his or her environmental beliefs subscale score was higher than his or her biological beliefs subscale score and the individual was in the contextual condition. In the biomedical condition, 13 participants were classified as a match and 12 participants were classified as a mismatch. In the contextual condition, 14 participants were classified as a match and 9 participants were classified as a mismatch.
A repeated measures ANOVA was conducted with DAQ-27 as the dependent variable and match, condition and time as independent variables. A significant main effect for match was found, F (1, 43) ϭ 4.98, p ϭ 0.031, with matched individuals demonstrating significantly lower levels of stigma compared with mismatched individuals collapsing across time (Table 3) . A significant interaction between match and condition was also found, F (1, 43) ϭ 12.19, p ϭ 0.001. Figure 1 shows that mismatched individuals in the biomedical condition exhibited higher levels of stigma than did all others. None of the remaining main or interaction effects reached significance. 
Behavioral Intentions
To examine the effect of the stigma reduction programs on behavioral intentions, 3 repeated measures ANOVAs were conducted with condition and time as independent variables and the significant other subscale, friend subscale, and parent subscale as dependent variables (Table 4 ).
Significant Other Subscale
On the Significant Other subscale, a repeated measures ANOVA with the 3 active conditions indicated a main effect for condition, F (2, 71) ϭ 7.44, p ϭ 0.001, with significant differences between conditions found at T1, F (2, 71) ϭ 8.65, p Ͻ 0.001, and T2, F (2, 71) ϭ 4.93, p ϭ 0.010, and a trend at T3, F (2, 71) ϭ 2.86, p ϭ 0.064. At T1, Tukey tests indicated that individuals in the contextual condition reported more significant other-related behavioral intentions than did those in the biomedical condition (p Ͻ 0.001); no other comparisons were significant. At T2, Tukey tests indicated that individuals in the contextual condition reported more significant other-related behavioral intentions than did those in the biomedical condition (p ϭ 0.010); no other comparisons were significant.
Friend Subscale
On the Friend subscale, a repeated measures ANOVA with the 3 active conditions indicated a main effect for condition, F (2, 71) ϭ 3.34, p ϭ 0.041, with significant differences between conditions found at T1, F (2, 71) ϭ 4.48, p ϭ 0.015, but not at T2, F (2, 71) ϭ 2.29, p ϭ 0.109, or at T3, F (2, 71) ϭ 1.21, p ϭ 0.305. At T1, Tukey tests indicated that individuals in the contextual condition reported more friend-related behavioral intentions than did those in the biomedical condition (p ϭ 0.013); no other comparisons were significant.
Parent Subscale
On the Parent subscale, a repeated measures ANOVA with the 3 active conditions indicated a main effect for condition, F (2, 71) ϭ 5.30, p ϭ 0.007, with significant differences between conditions found at T1, F (2, 71) ϭ 4.31, p ϭ 0.017, T2, F (2, 71) ϭ 4.44, p ϭ 0.015, and T3, F (2, 71) ϭ 4.18, p ϭ 0.019. At T1, Tukey tests indicated that individuals in the contextual condition reported more parent-related behavioral intentions than did those in the biomedical condition (p ϭ 0.020); no other comparisons were significant. At T2, Tukey tests indicated a trend in that individuals in the contextual condition reported more parentrelated behavioral intentions than did those in the biomedical condition (p ϭ 0.086); no other comparisons were significant. At T3, Tukey tests indicated that individuals in the contextual condition reported more parent-related behavioral intentions than did those in the biomedical condition (p ϭ 0.033) and that individuals in the control condition reported more parent-related 
Treatment Seeking
Few participants engaged in treatment seeking over the course of this study. Thus, these results are presented descriptively, excluding the 10 participants who reported already being in treatment. Only 3 individuals sought treatment by the 1-month followup. One individual in the contextual condition sought psychotherapy and 2 individuals in the control condition sought treatment (1 sought psychotherapy, 1 sought medication). Three additional participants, all from the contextual condition, reported seeking help from friends/family. Interestingly, all 4 of the participants in the contextual condition who engaged in these behaviors had matching beliefs about depression, as defined above. No participants in the biomedical condition engaged in initiating any help-seeking behavior.
DISCUSSION
In this study, the contextual and control programs significantly reduced stigmatizing attitudes compared with the no-program control but the biomedical program did not. However, analysis of effect sizes suggests that the biomedical condition might have shown some significant reduction, albeit less than the other conditions, with a larger sample size. The success of the control program is surprising, but whether this is a viable model of stigma reduction is unclear and in community settings it simply may be seen as insufficient. Research indicating whether this simple approach engenders treatment seeking is also necessary.
In the current study, participants' beliefs about depression moderated the effectiveness of the programs. Specifically, individuals shown a program that matched their beliefs about depression demonstrated lower levels of stigma after the programs than did individuals shown a program that did not match their beliefs. This was particularly evident for individuals who were shown the biomedical program and who viewed depression as predominantly environmental; they demonstrated significantly higher levels of stigma compared with individuals shown this program who viewed depression as predominantly biological. This suggests that preexisting beliefs about depression are an important variable and specifically that discussing depression as a biomedical problem may be risky for a subset of individuals who do not endorse this model. Future research is needed to replicate and clarify this finding. These results add to a growing body of literature suggesting shortcomings of the biomedical model of depression (e.g, Lam et al., 2005; Lam and Salkovskis, 2007; Mehta and Farina, 1997; Phelan, 2002; Walker and Read, 2002) . Given the relative success of the control program compared with the contextual program, it may be that it is important simply to not discuss depression as biomedical for some individuals.
In the current study, participants who received the contextual program reported greater behavioral intentions than those who received the biomedical program, which is consistent with prior research (Fischer and Farina, 1979) . This finding is particularly important because disclosing depression is a crucial step toward seeking treatment (Hinson and Swanson, 1993) . However, the current study could not adequately address treatment seeking because a depressed sample was not recruited resulting in limited power for this analysis. Nonetheless, descriptive data suggest that this may be worthwhile to pursue, and future research with depressed samples is necessary to examine these hypotheses adequately.
Theoretical Implications
Much of the prior research on stigma and stigma change has been empirical, and theoretical models have not been proposed. The current study was developed in that spirit; however, it is important to speculate on theoretical directions implied by the current research. One possible theoretical avenue to explore is attribution theory (Weiner, 1993) . Attribution theory predicts that specific patterns of causal attributions about a negative event-specifically, attributions that the causes of the event are controllable (vs. uncontrollable), internal (vs. external), and stable (vs. unstable) lead to lowered self-esteem and self-efficacy (McFarland and Ross, 1982; Weiner, 1995) . Regarding depression, it may be suggested that controllable, internal, and stable attributions about the causes of depression will lead to increased stigma and decreased help seeking.
It may be useful to consider the biomedical model of depression in light of this theory. By emphasizing that depression is a genetically based medical disease, the model clearly attributes the cause to uncontrollable factors; indeed one of the main functions of the model as used by advocacy groups is to argue that depression is not the depressed person's fault. Weiner (1995) suggested that attributions of controllability are a necessary precursor to judgments of responsibility and blame, and research has substantiated that uncontrollability attributions decrease blame, guilt, and anger (King, 2001; Mak and Wu, 2006; White et al., 2006) . In addition, to being uncontrollable, a biomedical model presents the causes of depression as internal to the individual (i.e., genetic determinants of biological functioning and levels of neurotransmitters) and as largely stable in that one cannot change one's genetic blueprint. Although there is less research on the effects of these attributions on stigma, theory suggests that they should attenuate the positive effects of the uncontrollability attribution.
Conversely, the contextual model focuses on environmental events and highlights that the individual is not to blame for such events. Thus, depression is also uncontrollable in this model-a favorable attribution. Furthermore, according to a contextual model, the causes of depression are external to the individual and because environments can change and environmental events are transient, the causes are unstable. Thus, a contextual model leads to a more favorable pattern of attributions than a biomedical model and should lead to more positive stigma change. This was found in the present study. The control program also may have resulted in a favorable set of attributions, but the rationale for this is unclear as it did not address causes of depression specifically.
Attribution theory also may offer insight into the significant match finding. Assuming the biomedical program was effective in changing attitudes, those who viewed depression as predominantly environmental may have shifted from a favorable set of attributions (consistent with the contextual model) to an unfavorable set of attributions (consistent with the biomedical model), resulting in greater stigma. Mismatches in the contextual condition would not be expected to result in this increase in stigma, because mismatched participants were shifting from an unfavorable to a more favorable set of attributions. Future research may profit from theoretically driven hypotheses based on these speculations.
Limitations and Future Directions
This study has several limitations. Notably, the no-program control was recruited separately and not randomized, limiting the confidence with which conclusions about comparisons with this condition can be held. Specifically, these individuals may have differed on important, unmeasured variables (e.g., familiarity with depression). Furthermore, the programs themselves were limited. Many community-based programs incorporate positive contact with individuals with mental illness into the programs, and this contact component has been shown to greatly enhance program effects (Penn et al., 1994) . Future research would benefit from including contact. This study is also limited by the use of an undergraduate sample with varying levels of depression, rather than a community sample. Furthermore, comprehensive data on the sample's psychi-
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The Journal of Nervous and Mental Disease • Volume 197, Number 2, February 2009 atric status was not assessed and future research would benefit from such an assessment. Stigma reduction programs are typically attended by depressed community members, their family and friends, and individuals otherwise sensitive to the topic. Thus, the relevance of the present data to the evaluation of community stigma reduction programs is unclear and is an important issue for future research. In addition, future research examining these hypotheses with ethnic minorities could be particularly advantageous. Specifically, African Americans view depression to be predominantly contextual (Sussman et al., 1987) and have a strong preference for psychotherapy (Dwight-Johnson et al., 2000) and thus, the match findings may be particularly relevant to this population. Finally, we offer posthoc theoretical interpretations of our findings. A compelling theoretical model of depression stigma and stigma change has yet to be presented; such a model would inform both the development of hypotheses and the interpretation of future findings.
CONCLUSION
This research contributes to the stigma reduction literature by comparing a biomedical, contextual, and control model of depression, each incorporated into a similar stigma reduction program. Overall, the contextual and control programs reduced stigma compared with a no-program control, but the biomedical program did not. Furthermore, participants' beliefs about depression moderated this main effect in that those whose beliefs about depression matched the content of the program displayed lower levels of stigma compared with those whose beliefs did not match. Specifically, individuals shown the biomedical program who believed depression to be predominantly environmental demonstrated a significantly more stigma than those who believed depression to be predominantly biological. Presenting the biomedical model may be risky for those who disagree with the model. Additionally, the contextual program engendered more behavioral intentions than did the biomedical model. Further research with community samples is necessary to replicate and evaluate these findings, and research based on theoretically driven hypotheses informed by attribution theory could add necessary depth to the findings. If generalizable, using a contextual model of depression within a stigma reduction program would impact overall stigma at levels at least equivalent to the biomedical model, engender more behavioral intentions, potentially activate increased treatment seeking, and offer less risk for a subgroup of individuals.
